Surrendered on reissue Feb 5, 2019 · Low confidence
20-year base term ends Dec 1, 2030
Surrendered on reissue Feb 5, 2019 · its term and maintenance fees continue in US RE47,221.
Held by AbbVie Inc.
Filed Dec 1, 2010 as application 12/958,115 · Granted Apr 23, 2013
Base term, 20 years from filing
Today
Surrendered Feb 5, 2019
2010
2030
Clock starts
Dec 1, 2010
Dec 1, 2010
No longer in force
Feb 5, 2019
Feb 5, 2019
Granted
Apr 23, 2013
Apr 23, 2013
Term would have run to
Dec 1, 2030
Dec 1, 2030
base term
after the term ends
fee events
Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
None
Term adjustment
No prosecution delay on this record.
None
Terminal disclaimer
No disclaimer on this record.
1 of 3
Maintenance fees paid
Fees paid on this patent before its reissue. Those after fall due on the reissue, which carries the term on.
11
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.
This patent's term is its 20-year base term, with no adjustment for prosecution delay. Confidence: Low. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Dec 1, 2010, when this application, 12/958,115, was filed | Dec 1, 2030 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | None on file | no change | High confidence |
| Terminal disclaimer cap | None on record | no cap applied | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | No fee event states this; the fee state is read from the payments the fee record holds; the fee record shows no payment for this window, and USPTO's status still reads "Patented Case" | no change | Low confidence |
| Reissue | US RE47,221 issued Feb 5, 2019, and this patent's term continues in it (35 U.S.C. 251, 252) | surrendered Feb 5, 2019 | High confidence |
| Surrendered on reissue | The steps above, in order | Feb 5, 2019 | Low confidence |
This family
| US 8,962,629 | In force Jan 2031 | Jan 2031 |
| US 8,426,411 | this patent Feb 2019 | Feb 2019 |
| Application 13/761,501 | Abandoned not computed | not computed |
| US 9,365,579 | In force Jun 2029 | Jun 2029 |
| Application 15/017,802 | Abandoned not computed | not computed |
| Application 15/152,823 | Abandoned not computed | not computed |
| US RE47,221 | In force Aug 2033 | Aug 2033 |
| Application 15/806,104 | Abandoned not computed | not computed |
8 of 11 applications in this family shown, earliest filings first. The applications whose file history this site holds. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| May 25, 2011 Reel 26337, frame 22 | Wishart, Neil; Argiriadi, Maria A; Calderwood, David J; Ericsson, Anna M; Fiamengo, Bryan A; Frank, Kristine E; Friedman, Michael; George, Dawn M; Goedken, Eric R; Josephsohn, Nathan S; Li, Biqin C; Morytko, Michael J; Stewart, Kent D; Voss, Jeffrey W; Wallace, Grier A; Wang, Lu; Woller, Kevin R | Abbott Laboratories | Assignment of Assignor's Interest |
| Jan 24, 2013 Reel 29688, frame 1 | Abbott Laboratories | AbbVie Inc. | Assignment of Assignor's Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
Citations
140
later US patents cite this one
That is top 5% of utility patents granted in 2013 in our data, the only group it is compared against.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.